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INTRODUCTORY PARAGRAPH
Variation in body fat distribution contributes to the metabolic sequelae of obesity. The genetic 
determinants of body fat distribution are poorly understood. The goal of this study was to gain new 
insights into the underlying genetics of body fat distribution by conducting sample-size weighted 
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fixed-effects genome-wide association meta-analyses in up to 9,594 women and 8,738 men for six 
ectopic fat traits in European, African, Hispanic, and Chinese ancestry populations, with and 
without sex stratification. In total, 7 new loci were identified in association with ectopic fat traits 
(ATXN1, UBE2E2, EBF1, RREB1, GSDMB, GRAMD3 and ENSA; P<5×10−8; FDR<1%). 
Functional analysis of these genes revealed that loss of function of both ATXN1 and UBE2E2 in 
primary mouse adipose progenitor cells impaired adipocyte differentiation, suggesting a 
physiological role for ATXN1 and UBE2E2 in adipogenesis. Future studies are necessary to 
further explore the mechanisms by which these genes impact adipocyte biology and how their 
perturbations contribute to systemic metabolic disease.
Keywords
GWAS; obesity; ectopic fat; adipocyte development; differentiation
MAIN TEXT
Variation in body fat distribution is associated with cardiometabolic risk, including diabetes, 
hypertension and coronary heart disease,1–5 and is at least partially independent of total 
adiposity. Adipose tissue can be quantified non-invasively using computed tomography (CT) 
and magnetic-resonance imaging (MRI) to measure fat volume and fat attenuation in 
different tissue compartments. We previously demonstrated that both indices, in addition to 
relative fat distribution, are important predictors of cardiometabolic risk.6–11
Several lines of evidence suggest a unique genetic component to body fat distribution. First, 
indices of body fat distribution are heritable with values ranging from 36–47%, even after 
adjustment for body mass index (BMI).12 Second, unique genetic loci exist for body fat 
distribution. For example, we identified a SNP associated with pericardial fat13 that was not 
associated with visceral fat,12 BMI or waist-hip-ratio (WHR).14,15 Third, several 
lipodystrophy syndromes, characterized by abnormal body fat distribution, are genetically 
mediated.16
The current study presents a genome-wide association study and meta-analysis of adipose 
tissue traits derived from imaging biomarkers (Supplementary Table 1) from 2.6 million 
SNPs in up to 9,594 women and 8,738 men of European, African, Hispanic and Chinese 
ancestry (see Supplementary Tables 2, 3 and 4) and uses mouse models to characterize 
selected loci.
Subcutaneous and visceral adipose tissue (SAT, VAT) were previously estimated to have 
heritabilities of 57% and 36%, respectively12,17 (Supplementary Table 5). To assess the 
genetic contribution to variation in fat attenuation traits, which serve as indirect markers of 
fat quality (SAT Hounsfield Units [SATHU] and VATHU), heritability (H2) was estimated in 
3,312 women and men in the Framingham Heart Study (FHS), and found to be between 29–
31% (P<1×10−15). To assess the shared genetic contribution between ectopic fat traits, the 
genetic correlations were estimated among 3,336 women and men in FHS. Moderate to 
strong statistically significant correlations were observed between almost all ectopic fat traits 
pairs (0.35 to 0.67 and −0.74 to −0.35, all P<5×10−4; Supplementary Table 6), suggesting 
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shared loci between ectopic fat traits. However, not all genes were shared between traits 
(P<5×10−11 for non-overlapping correlations for all pairwise comparisons). The genetic 
correlations across the ectopic fat traits are also reflected in the phenotypic correlations 
(Supplementary Table 7).
In this combined multiethnic sample-size weighted fixed-effects meta-analysis18,19 of up to 
18,332 participants, a total of 11 locus-trait associations (7 novel and 4 known) attained 
genome-wide significance (P<5×10−8) out of 27 genomic scans (from analysis of 9 traits 
and models in 3 strata – overall, women and men). Of the 7 novel loci, 3 were associated 
with volumetric subcutaneous (GSDMB) and visceral fat traits (GRAMD3 and RREB1), 2 
were associated with pericardial fat (ENSA and EBF1), 1 was associated with fat attenuation 
(ATXN1), and 1 was associated with relative fat distribution (VAT/SAT ratio [UBE2E2]) 
(Table 1; Supplementary Figures 1a–g; with imputation quality in Supplementary Table 8). 
Associations were robust across ancestry-stratified sensitivity analyses (Supplementary 
Figures 2a–g and 3a–g; Supplementary Table 9). Manhattan plots and QQ plots for each 
analysis showed minimal inflation of association test statistics (Supplementary Figures 4a–
g). The remaining 4 loci (LYPLAL1, LY86, FTO, TRIB2) attaining genome-wide 
significance were previously identified.12,13
rs2123685, located between the 3′ untranslated regions of ZPBP2 and GSDMB, was 
associated with SAT in women only (Pwomen=3.4×10−8, Supplementary Table 10a). 
Investigation of related ectopic traits among women revealed a direction-consistent nominal 
association with VAT (P=4.8×10−4). SNPs at FTO, the canonical-BMI locus, attained 
genome-wide significance in association with SAT in the overall sample (P=1.4×10−9).
The newly identified association at RREB1 with VATadjBMI (rs2842895, P=1.1×10−8) was 
observed in the overall sample and both sexes (Supplementary Table 10b). Examination of 
related ectopic traits demonstrated nominal associations with VAT and VAT/SAT ratio 
adjBMI (P=4.8×10−5 and P=8.9×10−6 respectively). The newly identified association of 
rs10060123 near GRAMD3 for VATadjBMI was specific to women (P=4.5×10−8). This 
locus was nominally associated with VAT and VAT/SAT ratio adjBMI in women 
(Supplementary Table 10c).
PAT represents distinct ectopic fat deposition around the heart. Two findings in the overall 
sample at the ENSA and EBF1 loci (P=2.8×10−9 and 1.0×10−9, respectively, Table 1) have 
not been previously associated with ectopic fat, general adiposity or body fat distribution. 
Associations at ENSA and EBF1 did not appear to be sex-specific (Supplementary Tables 
10d and 10e). Further investigation of the ENSA and EBF1 loci showed no associations with 
SAT, VAT or VAT/SAT ratio, underscoring their specificity to PAT. TRIB2 was associated 
with PAT in this and our prior meta-analysis (P<5×10−8).13
Cellular characteristics of fat quality, such as lipid content, vascularity, and adipocyte size 
and number, may be important factors influencing metabolic risk,7,10 but direct assessment 
is invasive. Fat attenuation traits, assessed with computed tomography, are correlated with 
fat quality characteristics20,21 and thus represent indirect markers of fat quality. ATXN1 was 
associated with SATHU among men only (P=1.4×10−8) with no association among women 
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(P=0.36, Supplementary Table 10f). Examination of related ectopic fat traits indicated 
similar direction of association with VATHU, and opposite direction for SAT and VAT 
(Supplementary Table 10f) which is consistent with epidemiology findings.7
The ratio of visceral to subcutaneous fat volumes (VAT/SAT ratio) represents the propensity 
to store fat viscerally. UBE2E2 was associated with VAT/SAT ratio (P=3.1×10−10); a 
nominal association was also identified with VAT (P=1.4×10−3) but not SAT, suggesting the 
finding is mostly driven by the higher relative abundance of VAT. The direction of 
association in both sex strata was consistent (Supplementary Table 10g). Two known body 
fat distribution loci, LYPLAL1 and LY86, were also associated with VAT/SAT ratio at 
genome-wide significance (Table 1), consistent with our prior analyses.12,22
Calculation of false discovery rate (FDR) to account for multiple testing across the 27 meta-
analyses showed all ectopic fat loci that attained genome-wide significance in each 
individual GWAS (P<5×10−8) also attained an FDR<1%.
To examine the association of the 7 newly identified ectopic fat loci with BMI and WHR, 
cross-trait evaluations for each lead SNP were performed in the most recent GIANT meta-
GWAS, with sample sizes ~10–20 times larger than the current study.14,15 Only 2 out of 14 
SNP-trait (BMI or WHR) associations were significant after Bonferroni correction for 
multiple testing (P<0.05/14=3.6×10−3; Supplementary Table 10a-g), highlighting the 
specificity and uniqueness of the ectopic fat loci.
To evaluate the relationship between the known 97 BMI and 49 WHR loci14,15 and ectopic 
fat traits, we examined the association for these loci with fat volume and relative fat volume 
traits among the combined multiethnic sample of women and men. Because the ectopic fat 
data may be underpowered to determine statistically significant results, we hypothesized that 
the direction of the BMI and WHR findings would be directionally consistent with 
abdominal ectopic traits, even if the p-values were not significant (Supplementary Table 11). 
Direction consistent SNP-trait associations between SAT and BMI were observed for 87 of 
97 loci (Pbinomial=8.9×10−17). When restricted to the 27 loci nominally associated with SAT 
(PSAT<0.05), all 27 SNP-SAT associations were directionally consistent with BMI 
(Pbinominal=7.5×10−9). SAT is not an ectopic fat depot and may represent a metabolic sink 
for healthier fat storage that is highly correlated with BMI and shares genetic risk factors (as 
shown with the enriched number of direction consistent associations), yet also represents a 
unique metric of fat distribution with unique genetic influences (as shown with the GSDMB-
SAT association). No other traits showed directionally consistent associations with the BMI 
or WHR (all P>0.05). These results further underscore how ectopic fat traits are uniquely 
disparate traits as compared to BMI and WHR.
Ectopic fat depots are associated with cardiometabolic risk and cardiovascular events.8–11 To 
gain insight into potential mechanisms linking these conditions, we evaluated the association 
of the new ectopic fat loci with traits from large-scale genetics consortia. Of 66 pairs of lead 
SNP-trait associations examined, 3 associations (UBE2E2-type 2 diabetes [T2D], EBF1-
triglycerides, and EBF1-HDL cholesterol) were statistically significant after Bonferroni 
correction for multiple testing (P<0.05/66=8×10−4; Supplementary Table 12).
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To examine if any of the new variants overlap with known regulatory regions in adipose 
tissue, lead SNPs and variants in linkage disequilibrium (LD) with the lead SNPs (r2>0.8) 
were interrogated using ENCODE Consortium data implemented in HaploReg23 and 
RegulomeDB.24 Except for ATXN1, all other loci contained SNPs in LD with the lead SNP 
that overlapped with known regulatory regions in adipose tissue. For example, the lead 
UBE2E2 variant (rs7374732), and other SNPs in LD, overlapped with a known enhancer 
region in adipose derived stem cells (Supplementary Table 13).
The list of candidate loci was further prioritized based on visual examination of regional 
association plots (Supplementary Figures 1a–g) and identification of 1) a localized 
association within a gene body at each locus (RREB1, ATXN1 and UBE2E2), or 2) a 
localized association near the gene body concomitant with the lack of other genes within 
1Mbp of the lead SNP (EBF1). In applying these criteria, four genes were selected for 
additional functional study.
To test the hypothesis that inter-depot differences in gene expression or their dynamic 
regulation during adipocyte development would identify candidates with a higher likelihood 
of functional significance, expression of 4 genes (Ebf1, Rreb1 Atxn1, Ube2e2) in murine 
SAT, VAT, and PAT depots was assessed by qPCR. Ube2e2 was expressed more highly in the 
perigonadal VAT of 6 week-old C57BL/6 mice relative to the SAT (2.1 fold, p<0.05, n=5) or 
PAT (2.6 fold, p<0.01, n=5), but no differences were observed for Ebf1, Rreb1 or Atxn1 
(Figure 1a). Differential gene expression of these 4 genes was also assessed in murine diet-
induced obesity. A 2.1 fold induction of Atxn1 expression in SAT of diet-induced obese 
mice was observed relative to lean controls (p<0.05, n=6). Significant differences were not 
observed for Ebf1, Rreb1, or Ube2e2 in response to the obesogenic stimulus (Figure 1b).
To explore a potential role for the candidate genes in adipocyte development, we examined 
their regulation during ex vivo adipogenic differentiation of progenitor-rich stromal-vascular 
cell fractions isolated from the subcutaneous and visceral depots of C57BL/6 mice. 
Candidate gene expression was measured at regular intervals during adipogenic 
differentiation. In progenitors isolated from both VAT and SAT, we observed a significant 
down-regulation of Atxn1, Ube2e2, and Ebf1 during adipogenesis (Figure 1c and 
Supplementary Figure 5). However, in all three instances the expression returned to near 
baseline levels by 96h post-adipogenic induction. In contrast, no significant transcriptional 
regulation of Rreb1 after adipogenic induction was observed (Supplementary Figure 5).
Both Atxn1 and Ube2Ee2 showed evidence of dynamic regulation of gene expression during 
adipogenesis with variable depot-specific expression in the murine models providing 
rationale to further explore their functional significance with a genetic loss-of-function 
assay. Knock-down of both genes with specific shRNA retroviral constructs during ex vivo 
adipogenesis of SAT progenitors impaired the formation of lipid-containing adipocytes 
relative to vector control infected cells, whereas only Ube2e2 knock-down impaired 
adipogenesis in progenitors isolated from VAT (Figure 1d,e).
Our findings provide insight into the genetics of body fat distribution. The scant number of 
significant associations observed between the ectopic fat loci and more general measures of 
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adiposity, such as BMI and WHR,14,15 demonstrates the specificity of the ectopic fat 
associations, highlights the utility of precise phenotyping of fat distribution, and suggests 
different mechanisms involved in ectopic fat storage compared to more general adiposity 
measures. This specificity was particularly notable for PAT loci, which demonstrate no 
associations with SAT, VAT, VAT/SAT ratio, BMI or WHR.
In addition, few cross-trait associations were observed for ectopic fat loci and other 
cardiometabolic traits, which is striking given the epidemiologic associations between 
ectopic fat and cardiometabolic risk1–5. One notable exception is UBE2E2, which is a 
known T2D locus25,26. The lead T2D SNP does not appear to be in LD with the lead SNP 
from our study (r2[rs7374732, rs7612463]<0.08 across all HapMap2 populations), and 
therefore likely represents an independent signal. The major allele at rs7374732 is associated 
with both lower VAT/SAT ratio and lower risk of T2D, suggesting that targeting relative fat 
distribution may have beneficial downstream effects.
Functional studies support a physiologic role for UBE2E2 and ATXN1 through regulation of 
adipocyte differentiation. ATXN1 encodes a chromatin binding factor involved in the 
repression of Notch signaling. It has been implicated in neurologic diseases, including 
spinocerebellar ataxia 1, but there are no reported associations between SNPs in ATXN1 and 
adiposity-related traits. In contrast, UBE2E2 is a known T2D GWAS locus,25–27 although 
the markers are in low LD with the lead SNP in the present study. UBE2E2 (3p24.2) 
encodes the ubiquitin-conjugating enzyme E2E2, which is expressed in human pancreas, 
liver, muscle and adipose tissues. The present GWAS results highlight UBE2E2 in 
association with the VAT/SAT ratio, a measure of the relative propensity to store fat in the 
visceral cavity rather than the subcutaneous compartment. We therefore speculate that SNP-
associated modulation of gene expression or function of the protein products may impact 
adiposity through an effect on adipocyte differentiation and relative impairments in 
adipocyte development may partially explain a default propensity to deposit viscerally as 
compared to subcutaneously.
Given the uniqueness of the ectopic fat traits, the sample size was limited in comparison to 
other meta-analyses. Moreover, identification of candidate genes based on proximity to a 
GWAS signal may miss long distance interactions between genes and regulatory domains. In 
contrast, multiethnic analyses, such as this study, not only enhance generalizability, but may 
also boost power for certain traits, particularly in contexts of limited allelic heterogeneity. 
The possibility of false positive loci is also a consideration, given the absence of external 
replication. However, all newly identified loci passed FDR<1%. Such statistical limitations 
are further mitigated in the case of ATXN1 and UBE2E2 by functional validation of these 
loci in murine adipose tissue.
Combining large-scale discovery human genetics with the detailed fat phenotyping and 
experiments in model organisms identified 7 new loci in association with ectopic fat traits, 
of which ATXN1 and UBE2E2 demonstrated a functional effect during adipocyte 
differentiation. Future studies should further explore the exact mechanism by which 
modulation of ATXN1 and UBE2E2 impact adipocyte differentiation and whether this effect 
causally impacts systemic metabolic disease.
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Online Methods
Study Participants
Up to 18,332 participants from 13 cohorts of European and African ancestry were available 
for analysis of subcutaneous and visceral adipose tissue volumetric traits, up to 11,596 from 
6 cohorts of European, African, Asian, and Hispanic ancestry were available for analysis of 
pericardial adipose volumetric traits, up to 12,519 participants from 5 cohorts of European 
and African ancestry were available for analysis of attenuation traits, and up to 18,191 
participants from 6 cohorts of European and African ancestry were available for analysis of 
relative fat distribution traits. This epidemiological sample constitutes the largest known 
collection of participants with radiologically derived ectopic fat measures and genetic data at 
the inception of this project. Supplementary Table 2 and 3 contain information regarding 
imaging modality used by each cohort, distribution by sex and ancestry per cohort for each 
trait analyzed and cohort descriptive information. All participants provided informed consent 
and each study was approved by their governing ethics committee.
Trait assessment
The traits measured in this study can be categorized into three groups: 1) fat volume 
measurements: subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT) and 
pericardial adipose tissue (PAT); 2) fat attenuation measurements: subcutaneous adipose 
tissue attenuation (SATHU) and visceral adipose tissue attenuation (VATHU); and 3) relative 
fat distribution measurements: visceral-to-subcutaneous adipose tissue volume ratio 
(VAT/SAT ratio). All volume-based measures were assessed by computed tomography (CT) 
or magnetic resonance imaging (MRI) following study-specific protocols; attenuation-based 
measures were assessed by CT following study specific protocols. Please see Supplementary 
Table 2 and Supplementary Note for further detail.
The following traits were created by each cohort in the overall sample, women and men: 
volume-based traits - SAT, VAT, VAT adjusted for BMI, PAT, PAT adjusted for height and 
weight; attenuation-based traits - SATHU and VATHU; relative-distribution traits - VAT/SAT 
ratio, VAT/SAT ratio adjusted for BMI pericardial traits. The rationale for including the 
ectopic fat traits, the adjustment models, and the sex-stratified analyses was 4-fold. First, 
ectopic fat measures are correlated with each other and with general adiposity and we 
wished to adjust for these factors as potential confounders or intermediates and to examine 
the genetic associations independent of the adjustment factor. Please see refer to 
Supplementary Table 7 for pairwise correlations of all traits within FHS, the largest 
participating cohort. For example, the correlation between VAT and BMI is 0.71 to 0.75 and 
adjusting for BMI when examining VAT provides the relative amount of VAT controlling for 
degree of general adiposity. Although the correlations between VAT/SAT ratio and BMI are 
modest, adjusting for BMI allowed us to examine the propensity to store fat viscerally 
compared to subcutaneously independent of general adiposity. Second, adjustment of 
covariates reduces the residual variance of the trait associated with the given covariate and 
thus increases power to detect genetic associations. Third, in the adiposity genetics literature 
there is evidence of sexually dimorphic loci in which the variance explained is larger in 
women versus men28 and association of the loci is markedly stronger in women compared to 
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men, and vice versa.14,22 Lastly, we adjusted PAT for height and weight to be consistent with 
our prior work13 (see Supplementary Table 1 for guide to nomenclature for traits and 
adjustment models).
Due to the known differences in body fat distribution by sex, each cohort created sex- and 
ancestry-specific residuals adjusted for age, age-squared, smoking status, measures of 
subpopulation stratification and family structure (if necessary). Family-based studies created 
an additional set of residuals from all participants (both women and men) to account for 
family structure when analyzing the overall sample. Participants with missing genotype, 
phenotype or covariate data were excluded from analysis as pre-specified in the analysis 
plan.
Study Specific Protocol
Trait measurements and descriptions from each cohort are available in Supplementary 
Material under “Cohort Specific Information and Protocols”.
Genotyping and Imputation
Each cohort was genotyped as specified in Supplementary Table 4 and performed ancestry-
specific imputation up to ~2.6 million SNPs based on the HapMap Project Phase 2 
haplotypes (http://hapmap.ncbi.nlm.nih.gov/index.html.en). All newly identified loci were 
imputed with imputation qualities >0.8 in each cohort. Imputation quality by locus and 
cohort are available in Supplementary Table 8.
Heritability Analysis
Heritability was estimated from the Framingham Heart Study using variance components 
analysis in SOLAR.16
Genetic Correlation Analysis
Pairwise genetic correlations between subcutaneous fat (volume and attenuation), visceral 
fat (volume and attenuation), ratio of visceral-to-subcutaneous fat and BMI were calculated 
using SOLAR16 in the Framingham Heart Study among 3,312 participants. We used 
residuals adjusted for age and sex. Two separate hypotheses were tested: 1) RhoG = 0 is the 
test for overlapping genetic correlations, and 2) absolute value (RhoG) = 1 is the test for 
non-overlapping genetic correlations.
Statistical Analysis
Within each cohort, by ancestry and by sex, genome-wide linear regression analyses were 
conducted on the 11 trait and model combinations assuming an additive genetic model using 
allele dosages. All traits approximated a normal distribution and untransformed traits were 
used for analysis. To prevent the undue influence of rare variants and/or of poorly imputed 
SNPs, we included variants with a minor allele count >10 and imputation quality >0.4 (for 
MaCH29) or >0.3 (for IMPUTE30) in each cohort.
For multiethnic analysis, we combined all cohort-specific results using a sample size-
weighted fixed-effects meta-analysis (Stouffer’s method) as implemented in METAL18,19 to 
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allow for differences in trait measurement and scaling due to different imaging modalities 
across cohorts. European and African ancestry cohorts contributed to all ectopic fat traits; 
Chinese and Hispanic ancestry cohorts contributed only to pericardial volume traits 
(Supplementary Table 3). All analyses were performed for the overall sample (ALL), among 
women only (WOMEN) and among men only (MEN). All analyses were corrected for 
genomic control at the cohort-level. We excluded variants with minor allele frequency 
(MAF)<5% due to the low power to detect associations of such variants. We set a traditional 
genome-wide significance threshold at P<5×10−8, the Bonferroni correction for the number 
of independent and common variants across the genome (~1 million SNPs). All p-values 
represent two-sided p-values unless otherwise specified. All regional association plots, 
Manhattan plots, and QQ plots were created using R version 3.1.1 (https://cran.r-
project.org/). Linkage disequilibrium plots were created using SNAP31 and the gap R 
package (https://www.jstatsoft.org/article/view/v023i08).
To correct for multiple testing, false discovery rate (FDR) was calculated across the 27 
ectopic fat GWAS scans using the qvalue R package (http://github.com/jdstorey/qvalue). 
FDR<1% was set as the multiple testing corrected significance threshold.
For mouse studies, individual cages of mice were randomly assigned in an un-blinded 
fashion to normal chow or high fat diet. Each in vivo study was conducted one time and no 
mice were excluded from the analyses. In the absence of a priori data regarding the variance 
of gene expression in the tissues of interest, we applied sample sizes that have in our 
experience been of sufficient size to detect a two-fold increase in gene expression. For 
normally distributed data from more than two groups (Shapiro-Wilk), an ANOVA test 
followed by Sidak’s correction for multiple testing was conducted (Figures 1a,c,e). For non-
normal data a Kruskal-Wallis test was used. For comparisons between two normally 
distributed groups (Figure 1b: chow versus high fat) a two-sided T-test was used, unless the 
data was non-normal, in which case a Mann-Whitney test was used. Data were expressed as 
mean, s.e.m. Significance was assigned for two-sided p<0.05. Data were analyzed and 
graphed using JMP 10.0 (SAS institute) and Prism 6 (Graphpad).
Sensitivity Analyses
To ensure the newly identified loci from our multiethnic analysis were robust and not driven 
by statistical outliers related to ancestry, ancestry-specific meta-analysis results were 
compared with each other with respect to the minor allele, the minor allele frequency and 
direction of the Z-score association statistic (Supplementary Table 9). Due to the scaling 
differences in imaging modalities across each cohort and use of the sample size weighted 
meta-analysis heterogeneity statistics cannot be calculated.
The lead SNP for the GSDMB locus associated with SAT in women was not observed in 
non-European ancestry cohorts and thus was not included in this analysis. For each of the 
remaining 6 lead SNPs from the newly identified ectopic fat loci, Z scores were directionally 
consistent across ancestry-specific meta-analyses (please see Supplementary Figure 2 for 
forest plots of each locus and Supplementary Figure 3 for linkage disequilibrium [LD] plots 
across ancestry). For 5 of these loci, the minor allele was identical across ancestries; only the 
minor allele of rs2842895 (RREB1) differed between the European ancestry and African 
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ancestry cohorts. This observation may explain the slight attenuation in the association of 
RREB1 and VATadjBMI after combining European and African ancestries in the multiethnic 
meta-analysis (PEuropean-ancestry=5.8×10−9 to Pmultiethnic=1.1×10−8), although the multiethnic 
result remains genome-wide significant.
Analyses of Related Traits
For each SNP attaining genome-wide significance in association with any ectopic fat trait, 
we extracted association results in each strata of analysis (ALL, WOMEN, and MEN) for 
related ectopic fat traits within our study.
To investigate the association of the new ectopic fat loci with measures of generalized 
adiposity (BMI) and central obesity (WHR) - two traits that are strongly correlated with, but 
distinct from ectopic fat - we evaluated the lead genome-wide significant SNPs in publically 
available datasets from the most recent GIANT meta-analyses of BMI and WHR.14,15
To investigate associations of new loci with cardio-metabolic traits that are 
epidemiologically associated with ectopic fat, cross-trait evaluations for the lead SNPs only 
were performed in the publically available datasets from the MAGIC (Meta-Analyses of 
Glucose and Insulin Consortium for fasting glucose and insulin32), GLGC (Global Lipids 
Genetics Consortium for high-density lipoprotein cholesterol, triglycerides and total 
cholesterol33), CARDIoGRAM+CAD consortium (Coronary ARtery DIsease Genome wide 
Replication and Meta-analysis [CARDIoGRAM] plus The Coronary Artery Disease [C4D] 
Genetics for coronary artery disease and myocardial infarction34,35), ICBP (International 
Consortium for Blood Pressure for systolic and diastolic blood pressure36), and DIAGRAM 
(DIAbetes Genetics Replication And Meta-analysis25).
Analysis of general adiposity and central adiposity loci
To evaluate the relationship between the known 97 BMI and 49 WHR loci14,15 with ectopic 
fat traits, we examined the association for these loci with fat volume and relative fat volume 
traits among the combined multiethnic sample of women and men. Because the ectopic fat 
data may be underpowered to determine statistically significant results, we hypothesized that 
the direction of the BMI and WHR findings would be directionally consistent with the 
ectopic fat traits, even if the p-values were not significant. Binominal tests were used to test 
the significance of direction consistent associations (1-sided p-values). If the binominal test 
across the BMI or WHR loci was significant, a second 1-sided binominal test was performed 
evaluating consistency of associations restricting to SNPs with nominally significant 
associations (P<0.05).
Functional Profiling - Bioinformatics and Annotation
To further characterize novel genome-wide significant loci, the following bioinformatics 
databases were queried for the lead ectopic fat loci: GWAS Catalog (https://www.ebi.ac.uk/
gwas/; access date: 10/15/2015) to investigate other traits associated with newly identified 
loci, and HaploReg23 and RegulomeDB24 to identify regulatory elements overlapping the 
loci for the index SNP and SNPs in LD with the index SNP (r2>0.8; Supplementary Table 
13). To contextualize the newly identified ectopic loci and the surrounding genes, SNIPPER 
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(https://github.com/welchr/Snipper.git) was used to search for biologically relevant 
mechanisms (Supplementary Table 14).
Variance Explained
The variance explained for each of the loci was approximated using the following formula 
R2=β2var(SNP)/var(ectopic fat trait), where β2 is the estimated effect of the SNP on the 
ectopic fat trait, and var(SNP)=2*MAFSNP*(1−MAFSNP). Because sample-size weighted 
fixed-effect meta-analysis does not estimate effect sizes, the beta-coefficient for the 
association between the SNP and ectopic fat trait and the variance of the ectopic fat trait 
were obtained from cohort level analysis per contributing study. The mean of the variance 
explained per locus across all contributing cohorts ranges from 0.1% to 4.4% 
(Supplementary Table 15).
Power Calculations
Power for discovery in the ectopic fat genomewide scan was calculated using GWAPower37 
using the range of sample size in this study (5,842–18,332 participants) and setting 
α=5×10−8. For the smallest sample size analyzed (N=5,842) we had ≥80% power to detect 
loci explaining at least 0.64% of the trait variance. For the largest sample size analyzed 
(N=18,332), we had ≥80% power to detect loci explaining at least 0.20% of the trait 
variance. For example, our novel loci explained from 0.15–4.4% of the trait variance for 
ectopic fat as seen in Supplementary Table 15.
To address the power to detect associations for the lookup analyses, we used GWAPower37 
with the maximum sample sizes from the each of the quantitative trait datasets (52,000–
94,000 participants), a modest range of variance explained (0.01–0.05%; based on the 
variance explained for each locus [0.1–4.4%] and the age- adjusted correlations between 
ectopic fat and the cardiometabolic trait of interest [R2=0.02–0.46]) and a Bonferroni 
corrected α=7.4×10-4 (~0.05/66 pairs of SNP-trait associations). For the smallest dataset 
(Fasting Insulin, N~52,000), we had 80% power to detect loci explaining at least 0.030% of 
the variance in fasting insulin. For the largest dataset (HDL-C and total cholesterol, 
N~94,000), we had 80% power to detect loci explaining 0.018% of the variance in HDL-C 
or total cholesterol. These calculations indicate that we largely had adequate power for a 
large portion of the SNP-trait associations.
eQTL analysis
Using a curated collection of 6 eQTL datasets in adipose-related tissues, index SNPs at 
newly identified ectopic fat loci were examined in association with transcript expression. 
Datasets were collected through publications, publically available sources, or private 
collaboration. The eQTL datasets met criteria for statistical thresholds for SNP-gene 
transcript associations as described in the original papers and were limited to index SNPs 
and SNPs in LD with the index SNP (r2>0.8) across all ancestries available in the 1000 
Genomes Project pilot (SNAP31). A general overview of the larger collection of more than 
50 eQTL studies from which the adipose-related datasets (omental, visceral and 
subcutaneous adipose,38–42) were derived from has been published.43 Additional eQTL data 
was integrated from online sources including ScanDB, the Broad Institute GTEx Portal, and 
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the Pritchard Lab (eqtl.uchicago.edu). Results for GTEx Analysis V4 for subcutaneous 
adipose tissue were downloaded from the GTEx Portal and then additionally filtered as 
described below (www.gtexportal.org41). Splicing QTL (sQTL) results generated with 
sQTLseeker with false discovery rate P≤0.05 were retained. For all gene-level eQTLs, if at 
least 1 SNP passed the tissue-specific empirical threshold in GTEx, the best SNP for that 
eQTL was always retained. All gene-level eQTL SNPs with P<1.67×10−11 were also 
retained, reflecting a global threshold correction of P=0.05/(30,000 genes × 1,000,000 tests).
Cis-eQTL analysis showed SNPs at ENSA (a locus identified in association with PAT) was 
correlated with multiple transcripts (MRPS21, CTSK and LASS2, P<10−4) in subcutaneous 
and omental adipose tissue (Supplementary Table 16), suggesting these may be the relevant 
transcripts at this locus and not ENSA, the closest gene to the lead association signal. 
However, the ENSA locus was not selected for functional validation, as there were too many 
genes in the region to practically follow up. No other eQTLs were identified.
Characterization in Model Organisms
Selection of Loci for Characterization—For functional follow-up and characterization 
of ectopic fat loci, four gene-trait associations were selected based on visual examination of 
regional association plots (Supplementary Figures 1a–g) for a localized association within a 
gene body at each locus (RREB1, ATXN1 and UBE2E2) or localized association near the 
gene body and the lack of other genes within 1Mbp of the lead SNP (EBF1) to increase the 
probability of experimentally testing the likely causal gene in murine models.
Mouse studies—Experiments were approved by and in compliance with the ethical 
regulations of the Harvard Medical Area Standing Committee on Animals. Male C57BL/6 
mice were purchased from Charles River and housed at 22 ± 2°C, with a 12h light (0700–
1900 h), 12h dark (1900-0700 h) cycle and ad libitum access to food and water. With the 
exception of the data shown in Supplementary Figure 6, experiments were conducted in 
male mice. Diet-induced obesity was modeled with high fat (D12492) and control chow 
(D12450J) matched for sucrose content (Research Diets, Inc.). Adipose tissue was 
harvested, homogenized in Trizol (Life Technologies), and RNA extracted according to the 
manufacturers protocol. cDNA was synthesized using the High-Capacity cDNA Reverse 
Transcription Kit (Life Technologies). qPCR was performed using iTaq Universal SYBR 
Green Supermix (Bio-Rad, Hercules, CA) on an iCycler (Bio-Rad) instrument. See 
Supplementary Table 17 for primer sequences used in these analyses. Gene expression was 
normalized to 18S. The delta-delta CT method was utilized to calculate fold change in 
transcript levels.
Comparison of baseline adipose-specific expression of Atxn1—Given that the 
SNP-ectopic fat association for ATXN1 was confined to men, we assessed gender-specific 
effects in mice of Atxn1 expression. There was no detectable gender effect on the baseline, 
adipose-specific expression of Atxn1 (Supplementary Figure 6).
Adipogenesis assay—Adipose tissue from C57BL/6 mice was minced and digested with 
collagenase D (Roche) in a shaking water bath (37C, 225rpm, 40min). The digest was 
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centrifuged at 400g for 10 min. Pelleted stromal vascular cells were filtered (40μm) and then 
washed with PBS and subjected to additional negative selection (CD31−/lineage−) adapted 
from previously performed methods44 using antibody coated microbeads (Miltenyi Biotec). 
Cells were cultured to confluence in collagen-coated plates and stimulated with 
dexamethasone, insulin and 3-isobutyl-1-methylxanthine to induce adipogenic 
differentiation. For genetic loss of function assays, validated shRNA sequences (Broad, 
Ube2e2: TRCN0000040962; Atxn1: TRCN0000240655) or scramble sequence were 
subcloned into a retroviral vector (pMKO.1). Gene knock-down efficiency was confirmed by 
qPCR in 3T3L1 cells, in each instance reproducibly achieving a minimum of 60% reduction 
of transcriptional activity. Differentiation into mature lipid-containing adipocytes was 
determined by oil-red-o (ORO) staining and quantified by measuring alcohol-extracted ORO 
dye at optical density 520 nm (OD520).
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Figure 1. Functional characterization of Atxn1, Ebf1, Rreb1 and Ube2e2
(a,b,e) Data is displayed as box/whisker plots where the center line represents the median, 
box limits contain the 25th–75th percentiles, and whiskers span max/min values.
(a) Gene expression measured by qPCR in murine subcutaneous (SAT), perigonadal visceral 
(VAT), and pericardial (PAT) adipose tissues (n=6 mice). Statistical significance was 
assessed using ANOVA and Sidak’s correction for multiple comparisons.
(b) Gene expression measured by qPCR in murine adipose tissues after 8 weeks of high fat 
feeding compared to normal chow fed controls (n=5 mice per group). Statistical significance 
was assigned using a two-sided T-test.
(c) Gene expression measured by qPCR in cultured adipocyte progenitors isolated from the 
subcutaneous (SAT) or perigonadal visceral (VAT) depots (n=4 replicates). Cells were 
expanded to confluence and then collected at intervals after induction of adipogenic 
differentiation. Data displayed as mean, error bar=s.e.m. Statistical significance was 
assessed using ANOVA and Sidak’s correction for multiple comparisons to time 0.
(d) Oil-red-o staining of progenitors isolated from subcutaneous adipose and exposed to 
retroviral delivery of shRNA constructs during ex vivo expansion and induction of 
adipogenesis. Relative to control vector carrying a scramble sequence, shRNA constructs 
specific for Atxn1 and Ube2e2 impaired adipogenic differentiation. Scale=1mm.
(e) Oil-red-o stain was alcohol extracted and quantified at OD520 (n=9 technical replicates). 
Statistical significance was assessed using ANOVA and Sidak’s correction for multiple 
comparisons to control (Scramble). Data representative of 3 independent experiments.
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